Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States?

Alexander TS, Miller MB, Gilligan P.

J Clin Microbiol. 2011 Jun;49(6):2086-92. doi: 10.1128/JCM.00589-11. Epub 2011 Apr 6.

2.

Screening for Mycobacterium tuberculosis using an interferon-gamma release assay.

Simpson T, Fox J, Crouse K, Field K.

J Public Health Manag Pract. 2012 Jul-Aug;18(4):E19-25. doi: 10.1097/PHH.0b013e31822adef1.

PMID:
22635200
3.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
4.

The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H.

Pediatr Infect Dis J. 2011 Aug;30(8):694-700. doi: 10.1097/INF.0b013e318214b915.

PMID:
21427627
5.

Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?

Denkinger CM, Dheda K, Pai M.

Clin Microbiol Infect. 2011 Jun;17(6):806-14. doi: 10.1111/j.1469-0691.2011.03555.x. Review.

6.

Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.

Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M.

Thorax. 2012 Jan;67(1):62-70. doi: 10.1136/thx.2010.143180. Epub 2011 Jan 12. Review.

PMID:
21228420
7.

Screening for tuberculosis infection prior to initiation of anti-TNF therapy.

Lalvani A, Millington KA.

Autoimmun Rev. 2008 Dec;8(2):147-52. doi: 10.1016/j.autrev.2008.07.011. Epub 2008 Aug 13. Review.

8.

Diagnostic and prognostic value of Mycobacterium tuberculosis complex specific interferon gamma release assay in patients with tuberculous meningitis.

Vidhate MR, Singh MK, Garg RK, Verma R, Shukla R, Goel MM, Makker A, Jain A.

J Infect. 2011 May;62(5):400-3. doi: 10.1016/j.jinf.2011.03.009. Epub 2011 Mar 30. No abstract available.

PMID:
21457728
9.

Response to "Tuberculosis Screening on a Health Science Campus: Use of QuantiFERON-TB Gold Test for Students and Employees".

Rothel J, Veeser PI.

J Am Coll Health. 2008 Jul-Aug;57(1):121-4; author reply 121. doi: 10.3200/JACH.57.1.121-124. No abstract available.

PMID:
18682355
10.

Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment.

Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Santoro G, Balato N, Castiglione F, Scarpa R, Perna F, Signoriello G, Galati D, Ponticiello A, Sanduzzi A.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):907-13. doi: 10.1007/s10096-008-0519-1. Epub 2008 May 10.

PMID:
18470544
11.

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.

Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM.

BMC Infect Dis. 2006 Mar 15;6:47.

12.

Assessment of Imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis.

Tuuminen T, Tavast E, Väisänen R, Himberg JJ, Seppälä I.

Clin Vaccine Immunol. 2010 Apr;17(4):596-601. doi: 10.1128/CVI.00320-09. Epub 2010 Feb 24.

13.

Short-term reproducibility of a commercial interferon gamma release assay.

Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, Du Plessis N, Kidd M, Beyers N, Walzl G, Hesseling AC.

Clin Vaccine Immunol. 2009 Aug;16(8):1170-5. doi: 10.1128/CVI.00168-09. Epub 2009 Jun 17.

14.

Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children.

Lewinsohn DA, Lobato MN, Jereb JA.

Curr Opin Pediatr. 2010 Feb;22(1):71-6. doi: 10.1097/MOP.0b013e3283350301. Review.

PMID:
19952926
15.

Interferon gamma release assays: principles and practice.

Lalvani A, Pareek M.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Review.

PMID:
19783328
17.

Tuberculosis screening on a health science campus: use of QuantiFERON-TB Gold Test for students and employees.

Veeser PI, Smith PK, Handy B, Martin SR.

J Am Coll Health. 2007 Sep-Oct;56(2):175-80.

PMID:
17967764
18.

Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.

Papay P, Eser A, Winkler S, Frantal S, Primas C, Miehsler W, Angelberger S, Novacek G, Mikulits A, Vogelsang H, Reinisch W.

Eur J Clin Invest. 2011 Oct;41(10):1071-6. doi: 10.1111/j.1365-2362.2011.02502.x. Epub 2011 Mar 17.

PMID:
21413978
19.

The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident.

Bradshaw L, Davies E, Devine M, Flanagan P, Kelly P, O'Connor K, Drobniewski F, Nikolayevskyy V, Abubakar I.

PLoS One. 2011;6(6):e20770. doi: 10.1371/journal.pone.0020770. Epub 2011 Jun 13.

20.

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.

Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M.

BMC Infect Dis. 2011 Nov 15;11:319. doi: 10.1186/1471-2334-11-319.

Supplemental Content

Support Center